Goldstein Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1963807 Madison, WI

Position in GILD

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$322,798

-$33,013 QoQ

Shares Held

2,555

+0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#1,608

of 2,266 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Goldstein Advisors, LLC holds $3,737,042 across 6 Drug Manufacturers - General names. GILD ranks #5 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	3,947	$1,002,419
2	ABBV	AbbVie Inc.	3,951	$994,229
3	LLY	ELI LILLY & Co	525	$629,700
4	MRK	Merck & Co., Inc.	4,434	$569,769
5	GILD	Gilead Sciences, Inc. This page	2,555	$322,798
6	NVO	Novo Nordisk A S	4,550	$218,127

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$322,798	2,555	+0.1%	Shares	Sole	2026-07-20
2026-03-31	$355,811	2,553	+7.3%	Shares	Sole	2026-04-28
2025-12-31	$292,121	2,380	0.0%	Shares	Sole	2026-02-10
2025-09-30	$264,180	2,380	-1.9%	Shares	Sole	2025-10-21
2025-06-30	$268,859	2,425	+1.5%	Shares	Sole	2025-07-29
2025-03-31	$267,687	2,389	+1.4%	Shares	Sole	2025-04-23
2024-12-31	$217,531	2,355	—	Shares	Sole	2025-01-17
No filing history on record for this holder in this stock.